The WHO's cancer research agency has classified Hydrochlorothiazide, Voriconazole and Tacrolimus as Group 1 carcinogens based on scientific evidence. Health experts, however, stress that patients should continue prescribed treatment and consult doctors before making any changes, as uncontrolled hypertension poses greater immediate risks.
